Jeffrey W. Albers Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey W. Albers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey W. Albers. Jeffrey W. Albers is CEO and President in Blueprint Medicines Corp ($BPMC) and Director in Magenta Therapeutics, Inc. ($MGTA) and Director in Kymera Therapeutics, Inc. ($KYMR).
Latest Insider Trading Transactions of Jeffrey W. Albers
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BPMC, KYMR, MGTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 7,500 | 14,025 | 166,403 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 15.01 | 17,500 | 262,675 | 122,500 | |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.89 | 2,953 | 271,351 | 172,448 | 175.4 K to 172.4 K (-1.68 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 92.62 | 16,383 | 1,517,393 | 175,401 | 191.8 K to 175.4 K (-8.54 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.33 | 5,664 | 528,621 | 191,784 | 197.4 K to 191.8 K (-2.87 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 15.01 | 17,500 | 262,675 | 197,448 | 179.9 K to 197.4 K (+9.73 %) |
| May 14 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 7,500 | 14,025 | 179,948 | 172.4 K to 179.9 K (+4.35 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 10,000 | 88,000 | 7,170 | |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 8,417 | 728,996 | 172,448 | 180.9 K to 172.4 K (-4.65 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 88.63 | 569 | 50,430 | 180,865 | 181.4 K to 180.9 K (-0.31 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 100 | 8,661 | 181,434 | 181.5 K to 181.4 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 89.18 | 100 | 8,918 | 181,534 | 181.6 K to 181.5 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.18 | 404 | 36,433 | 181,634 | 182 K to 181.6 K (-0.22 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.99 | 3,000 | 272,970 | 182,038 | 185 K to 182 K (-1.62 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.78 | 5,296 | 486,067 | 185,038 | 190.3 K to 185 K (-2.78 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.21 | 1,100 | 102,531 | 190,334 | 191.4 K to 190.3 K (-0.57 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 10,000 | 88,000 | 191,434 | 181.4 K to 191.4 K (+5.51 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 17,170 | |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 119.18 | 5,000 | 595,900 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Dec 16 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 22,170 | |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 97.61 | 6,521 | 636,515 | 141,434 | 148 K to 141.4 K (-4.41 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 98.13 | 4,483 | 439,917 | 147,955 | 152.4 K to 148 K (-2.94 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.55 | 4,869 | 484,709 | 152,438 | 157.3 K to 152.4 K (-3.10 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 100.11 | 4,127 | 413,154 | 157,307 | 161.4 K to 157.3 K (-2.56 %) |
| Nov 18 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 5,000 | 44,000 | 42,170 | |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.17 | 5,000 | 495,850 | 141,434 | 146.4 K to 141.4 K (-3.41 %) |
| Oct 09 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 5,000 | 44,000 | 146,434 | 141.4 K to 146.4 K (+3.54 %) |
| Aug 21 2020 | KYMR | Kymera Therapeutic ... | Albers Jeffrey W. | Director | Option Exercise | A | 20.00 | 40,127 | 802,540 | 40,127 | |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 47,170 | |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 74.60 | 8,597 | 641,336 | 141,434 | 150 K to 141.4 K (-5.73 %) |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 75.34 | 11,403 | 859,102 | 150,031 | 161.4 K to 150 K (-7.06 %) |
| Aug 21 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Jun 09 2020 | MGTA | Magenta Therapeuti ... | Albers Jeffrey W. | Director | Option Exercise | A | 9.99 | 18,188 | 181,698 | 18,188 | |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 20,000 | 176,000 | 67,170 | |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 63.93 | 9,568 | 611,682 | 141,434 | 151 K to 141.4 K (-6.34 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 64.75 | 4,282 | 277,260 | 151,002 | 155.3 K to 151 K (-2.76 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 65.77 | 6,150 | 404,486 | 155,284 | 161.4 K to 155.3 K (-3.81 %) |
| May 14 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 20,000 | 176,000 | 161,434 | 141.4 K to 161.4 K (+14.14 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 19,920 | 175,296 | 87,170 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 80 | 150 | 0 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 173,903 | |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.40 | 3,337 | 168,185 | 141,434 | 144.8 K to 141.4 K (-2.31 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.30 | 8,850 | 454,005 | 144,771 | 153.6 K to 144.8 K (-5.76 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 52.11 | 2,100 | 109,431 | 153,621 | 155.7 K to 153.6 K (-1.35 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 53.54 | 1,936 | 103,653 | 155,721 | 157.7 K to 155.7 K (-1.23 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 54.62 | 3,293 | 179,864 | 157,657 | 161 K to 157.7 K (-2.05 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 55.34 | 484 | 26,785 | 160,950 | 161.4 K to 161 K (-0.30 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 19,920 | 175,296 | 161,434 | 141.5 K to 161.4 K (+14.08 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 80 | 150 | 141,514 | 141.4 K to 141.5 K (+0.06 %) |
| Mar 25 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 141,434 | 121.4 K to 141.4 K (+16.47 %) |
| Mar 11 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.97 | 2,277 | 118,336 | 121,434 | 123.7 K to 121.4 K (-1.84 %) |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 54.13 | 90,000 | 4,871,700 | 90,000 | |
| Mar 03 2020 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Grant | A | 0.00 | 45,000 | 0 | 123,711 | 78.7 K to 123.7 K (+57.17 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 2,000 | 17,600 | 107,090 | |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 18,000 | 33,660 | 80 | |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 74.56 | 11,744 | 875,633 | 48,961 | 60.7 K to 49 K (-19.35 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 75.36 | 7,656 | 576,956 | 60,705 | 68.4 K to 60.7 K (-11.20 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 76.16 | 600 | 45,696 | 68,361 | 69 K to 68.4 K (-0.87 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 2,000 | 17,600 | 68,961 | 67 K to 69 K (+2.99 %) |
| Nov 20 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 18,000 | 33,660 | 66,961 | 49 K to 67 K (+36.76 %) |
| Oct 30 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 193,903 | |
| Oct 30 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 18,080 | |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 81.33 | 12,166 | 989,461 | 28,961 | 41.1 K to 29 K (-29.58 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 82.04 | 6,634 | 544,253 | 41,127 | 47.8 K to 41.1 K (-13.89 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 82.85 | 300 | 24,855 | 47,761 | 48.1 K to 47.8 K (-0.62 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 84.42 | 800 | 67,536 | 48,061 | 48.9 K to 48.1 K (-1.64 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 85.56 | 100 | 8,556 | 48,861 | 49 K to 48.9 K (-0.20 %) |
| Aug 21 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 5,000 | 9,350 | 38,080 | |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 99.06 | 5,000 | 495,300 | 28,961 | 34 K to 29 K (-14.72 %) |
| Jun 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 5,000 | 9,350 | 33,961 | 29 K to 34 K (+17.26 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 43,080 | |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 82.37 | 1,900 | 156,503 | 28,961 | 30.9 K to 29 K (-6.16 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 83.81 | 4,050 | 339,431 | 30,861 | 34.9 K to 30.9 K (-11.60 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 84.61 | 4,859 | 411,120 | 34,911 | 39.8 K to 34.9 K (-12.22 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 85.72 | 9,191 | 787,853 | 39,770 | 49 K to 39.8 K (-18.77 %) |
| Jun 14 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |
| Jun 11 2019 | MGTA | Magenta Therapeuti ... | Albers Jeffrey W. | Director | Option Exercise | A | 13.40 | 18,188 | 243,719 | 18,188 | |
| Mar 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 63,080 | |
| Mar 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 85.61 | 6,126 | 524,447 | 28,961 | 35.1 K to 29 K (-17.46 %) |
| Mar 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.41 | 9,423 | 814,241 | 35,087 | 44.5 K to 35.1 K (-21.17 %) |
| Mar 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 87.44 | 4,451 | 389,195 | 44,510 | 49 K to 44.5 K (-9.09 %) |
| Mar 19 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 48,961 | 29 K to 49 K (+69.06 %) |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 0.00 | 29,750 | 0 | 29,750 | |
| Mar 05 2019 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 86.60 | 110,500 | 9,569,300 | 110,500 | |
| Nov 21 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 28,961 | 54,157 | 886,073 | |
| Nov 21 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 28,961 | 54,157 | 28,961 | 0 to 29 K |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 915,034 | |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 62.66 | 100 | 6,266 | 0 | 100 to 0 (-100.00 %) |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 63.30 | 17,300 | 1,095,090 | 100 | 17.4 K to 100 (-99.43 %) |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 64.18 | 1,500 | 96,270 | 17,400 | 18.9 K to 17.4 K (-7.94 %) |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 65.53 | 1,100 | 72,083 | 18,900 | 20 K to 18.9 K (-5.50 %) |
| Nov 07 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 20,000 | 0 to 20 K |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 935,034 | |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 68.48 | 802 | 54,921 | 0 | 802 to 0 (-100.00 %) |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 69.64 | 800 | 55,712 | 802 | 1.6 K to 802 (-49.94 %) |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 70.48 | 12,219 | 861,195 | 1,602 | 13.8 K to 1.6 K (-88.41 %) |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 71.22 | 6,179 | 440,068 | 13,821 | 20 K to 13.8 K (-30.89 %) |
| Aug 08 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 20,000 | 0 to 20 K |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | Albers Jeffrey W. | Director | Option Exercise | C | 0.00 | 10,729 | 0 | 0 | |
| Jun 27 2018 | MGTA | Magenta Therapeuti ... | Albers Jeffrey W. | Director | Buy | C | 0.00 | 4,152 | 0 | 4,152 | 0 to 4.2 K |
| May 09 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 955,034 | |
| May 09 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 78.56 | 8,320 | 653,619 | 0 | 8.3 K to 0 (-100.00 %) |
| May 09 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 79.15 | 11,680 | 924,472 | 8,320 | 20 K to 8.3 K (-58.40 %) |
| May 09 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 20,000 | 0 to 20 K |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 975,034 | |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 88.17 | 1,300 | 114,621 | 0 | 1.3 K to 0 (-100.00 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 89.07 | 2,284 | 203,436 | 1,300 | 3.6 K to 1.3 K (-63.73 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.52 | 600 | 54,312 | 3,584 | 4.2 K to 3.6 K (-14.34 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.66 | 4,100 | 375,806 | 4,184 | 8.3 K to 4.2 K (-49.49 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 92.76 | 1,900 | 176,244 | 8,284 | 10.2 K to 8.3 K (-18.66 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.89 | 3,794 | 356,219 | 10,184 | 14 K to 10.2 K (-27.14 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 94.79 | 6,022 | 570,825 | 13,978 | 20 K to 14 K (-30.11 %) |
| Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 20,000 | 0 to 20 K |
| Feb 20 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 81.44 | 170,000 | 13,844,800 | 995,034 | |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 24,514 | 45,841 | 825,034 | |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 68.95 | 1,100 | 75,845 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 69.74 | 16,469 | 1,148,548 | 1,100 | 17.6 K to 1.1 K (-93.74 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 70.40 | 7,432 | 523,213 | 17,569 | 25 K to 17.6 K (-29.73 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 71.67 | 2,600 | 186,342 | 25,001 | 27.6 K to 25 K (-9.42 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 72.91 | 1,999 | 145,747 | 27,601 | 29.6 K to 27.6 K (-6.75 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 73.89 | 400 | 29,556 | 29,600 | 30 K to 29.6 K (-1.33 %) |
| Nov 08 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 24,514 | 45,841 | 30,000 | 5.5 K to 30 K (+446.85 %) |
| Aug 09 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.70 | 10,000 | 507,000 | 5,486 | 15.5 K to 5.5 K (-64.57 %) |
| Aug 09 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 48.29 | 2,786 | 134,536 | 15,486 | 18.3 K to 15.5 K (-15.25 %) |
| Aug 09 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 49.21 | 17,214 | 847,101 | 18,272 | 35.5 K to 18.3 K (-48.51 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 49.10 | 2,229 | 109,444 | 35,486 | 37.7 K to 35.5 K (-5.91 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 50.22 | 10,205 | 512,495 | 37,715 | 47.9 K to 37.7 K (-21.30 %) |
| Jun 30 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 51.21 | 7,566 | 387,455 | 47,920 | 55.5 K to 47.9 K (-13.64 %) |
| Mar 16 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 39.75 | 980 | 38,955 | 55,486 | 56.5 K to 55.5 K (-1.74 %) |
| Mar 16 2017 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 40.04 | 19,020 | 761,561 | 56,466 | 75.5 K to 56.5 K (-25.20 %) |
| Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 23.22 | 1,008 | 23,406 | 75,486 | 76.5 K to 75.5 K (-1.32 %) |
| Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 23.22 | 1,008 | 23,406 | 75,486 | 76.5 K to 75.5 K (-1.32 %) |
| Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 22.84 | 15,992 | 365,257 | 76,494 | 92.5 K to 76.5 K (-17.29 %) |
| Aug 10 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 22.84 | 15,992 | 365,257 | 76,494 | 92.5 K to 76.5 K (-17.29 %) |
| Jun 07 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 20.03 | 17,000 | 340,510 | 92,486 | 109.5 K to 92.5 K (-15.53 %) |
| Feb 05 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | A | 15.01 | 140,000 | 2,101,400 | 679,548 | |
| Apr 08 2016 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 20.42 | 17,000 | 347,140 | 109,486 | 126.5 K to 109.5 K (-13.44 %) |
| Nov 12 2015 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 21.87 | 7,000 | 153,090 | 126,486 | 133.5 K to 126.5 K (-5.24 %) |
| Nov 04 2015 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 21.02 | 10,000 | 210,200 | 133,486 | 143.5 K to 133.5 K (-6.97 %) |
Page: 1